About: Otamixaban     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : umbel-rc:DrugProduct, within Data Space : dbpedia.org associated with source document(s)
QRcode icon
http://dbpedia.org/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FOtamixaban&graph=http%3A%2F%2Fdbpedia.org&graph=http%3A%2F%2Fdbpedia.org

Otamixaban (INN) is an experimental injectable anticoagulant direct factor Xa inhibitor that was investigated for the treatment for acute coronary syndrome. In 2013, Sanofi announced that it had ended development of the drug candidate after poor performance in a Phase III clinical trial.

AttributesValues
rdf:type
rdfs:label
  • Otamixaban (it)
  • オタミキサバン (ja)
  • Otamixaban (en)
  • Otamixaban (pt)
rdfs:comment
  • Otamixaban (INN) is an experimental injectable anticoagulant direct factor Xa inhibitor that was investigated for the treatment for acute coronary syndrome. In 2013, Sanofi announced that it had ended development of the drug candidate after poor performance in a Phase III clinical trial. (en)
  • オタミキサバン（Otamixaban）は、キサバン（xaban）と付くことからも明らかなように、の1種である。CAS登録番号は193153-04-7。 (ja)
  • L'Otamixaban (INN) è un anticoagulante iniettabile inibitore del fattore Xa sperimentale , che fu valutato per il trattamento della Sindrome coronarica acuta . Nel 2013, Sanofi annunciò che interrompeva lo sviluppo del farmaco per scarsi risultati negli studi clinici in fase III (it)
  • Otamixaban é um fármaco que age como inibidor direto do fator Xa. (pt)
foaf:depiction
  • http://commons.wikimedia.org/wiki/Special:FilePath/Otamixaban.svg
  • http://commons.wikimedia.org/wiki/Special:FilePath/Otamixaban_3D.png
dcterms:subject
Wikipage page ID
Wikipage revision ID
Link from a Wikipage to another Wikipage
sameAs
dbp:wikiPageUsesTemplate
thumbnail
ATC prefix
  • none (en)
c
CAS number
ChEMBL
ChemSpiderID
H
image
  • Otamixaban 3D.png (en)
IUPAC name
  • Methyl -2-{3-[aminomethyl]benzyl}-3-{[4-benzoyl]amino}butanoate (en)
n
O
PubChem
SMILES
  • O=C[C@H][C@H]C (en)
StdInChI
StdInChIKey
  • PFGVNLZDWRZPJW-OPAMFIHVSA-N (en)
UNII
  • S173RED00L (en)
Verifiedfields
  • changed (en)
verifiedrevid
has abstract
  • Otamixaban (INN) is an experimental injectable anticoagulant direct factor Xa inhibitor that was investigated for the treatment for acute coronary syndrome. In 2013, Sanofi announced that it had ended development of the drug candidate after poor performance in a Phase III clinical trial. (en)
  • オタミキサバン（Otamixaban）は、キサバン（xaban）と付くことからも明らかなように、の1種である。CAS登録番号は193153-04-7。 (ja)
  • L'Otamixaban (INN) è un anticoagulante iniettabile inibitore del fattore Xa sperimentale , che fu valutato per il trattamento della Sindrome coronarica acuta . Nel 2013, Sanofi annunciò che interrompeva lo sviluppo del farmaco per scarsi risultati negli studi clinici in fase III (it)
  • Otamixaban é um fármaco que age como inibidor direto do fator Xa. (pt)
gold:hypernym
prov:wasDerivedFrom
page length (characters) of wiki page
CAS number
  • 193153-04-7
ChEMBL
  • 46618
FDA UNII code
  • S173RED00L
PubChem
  • 5496659
foaf:isPrimaryTopicOf
is Link from a Wikipage to another Wikipage of
is foaf:primaryTopic of
Faceted Search & Find service v1.17_git139 as of Feb 29 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (62 GB total memory, 48 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software